Metabolism - Clinical and Experimental
Volume 45, Issue 11 , Pages 1368-1374, November 1996

l-Arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals

  • Kenji Seri

      Affiliations

    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan
  • ,
  • Kazuko Sanai

      Affiliations

    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan
  • ,
  • Noriki Matsuo

      Affiliations

    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan
  • ,
  • Kiyoshi Kawakubo

      Affiliations

    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan
  • ,
  • Changyong Xue

      Affiliations

    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan
  • ,
  • Shuji Inoue

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Shuji Inoue, MD, Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, 1-23-1 Toyama Shinjuku-ku, Tokyo, 162 Japan.
    • Pharmacological Section, Central Research Laboratory, GODO SHUSEI Co, Matsudo City, Chiba, Japan
    • Division of Geriatric Health and Nutrition, National Institute of Health and Nutrition, Tokyo, Japan

Received 2 December 1995; accepted 4 June 1996.

Abstract 

The objective of this study was to investigate the effects of l-arabinose on intestinal α-glucosidase activities in vitro and to evaluate its effects on postprandial glycemic responses in vivo. L-Arabinose inhibited the sucrase activity of intestinal mucosa in an uncompetitive manner (Ki, 2 mmol/L). Neither the optical isomer d-arabinose nor the disaccharide l-arabinobiose inhibited sucrase activity, whereas d-xylose was as potent as l-arabinose in inhibiting this activity. l-Arabinose and d-xylose showed no inhibitory effect on the activities of intestinal maltase, isomaltase, trehalase, lactase, and glucoamylase, or pancreatic amylase. In contrast, a known α-glucosidase inhibitor, acarbose, competitively inhibited (ki, 1.1 μmol/L) sucrase activity and also inhibited intestinal maltase, glucoamylase, and pancreatic amylase. l-Arabinose suppressed the increase of blood glucose after sucrose loading dose-dependently in mice (ED50, 35 mg/kg), but showed no effect after starch loading. The suppressive effect of d-xylose on the increase of blood glucose after sucrose loading was 2.4 times less than that of l-arabinose, probably due to intestinal absorption of the former. Acarbose strongly suppressed glycemic responses in both sucrose loading (ED50, 1.1 mg/kg) and starch loading (ED50, 1.7 mg/kg) in mice. l-Arabinose suppressed the increase of plasma glucose and insulin in rats after sucrose loading, the suppression of the former being uninterruptedly observed in mice for 3 weeks. Thus, the results demonstrated that l-arabinose selectively inhibits intestinal sucrase activity in an uncompetitive manner and suppresses the glycemic response after sucrose ingestion by inhibition of sucrase activity.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(96)90117-1

Metabolism - Clinical and Experimental
Volume 45, Issue 11 , Pages 1368-1374, November 1996